v3.26.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
Schedule of Cash and Cash Equivalents
The following table provides a reconciliation of cash and restricted cash presented on our balance sheets to amounts shown in our condensed consolidated statements of cash flows:

As of March 31,
20262025
(in thousands)
Cash and cash equivalents$9,775 $6,255 
Restricted cash – current5,428 3,247 
Restricted cash – noncurrent17,400 14,250 
Total cash, cash equivalents and restricted cash$32,603 $23,752 
Schedule of Restricted Cash and Restricted Cash Equivalents
The following table provides a reconciliation of cash and restricted cash presented on our balance sheets to amounts shown in our condensed consolidated statements of cash flows:

As of March 31,
20262025
(in thousands)
Cash and cash equivalents$9,775 $6,255 
Restricted cash – current5,428 3,247 
Restricted cash – noncurrent17,400 14,250 
Total cash, cash equivalents and restricted cash$32,603 $23,752 
Schedule of Supplemental Cash Flow
The following are our supplemental cash flow disclosures for the three months ended March 31, 2026 and 2025:

Three Months Ended March 31,
20262025
(in thousands)
Supplemental cash flow disclosures:
Interest paid, net of amounts capitalized$109,626 $95,599 
Income tax payments (refunds)(876)1,614 
Non-cash investing and financing activities:
Capital expenditures included in accounts payable and accrued liabilities$238,168 $188,896 
Equity consideration for acquisitions— 82,145 
Vital purchase price allocation adjustment
11,728 — 
Right-of-use assets obtained in exchange for leases9,407 3,055